g the COVID-19 pandemic, if clinicians, healthcare service-providing staff, nurses, and doctors were battling at the forefront, then the Clinical Research Organizations (CROs) have been working hard in the background to develop effective vaccines to fight this novel coronavirus.
With millions of cases emerging every day globally, the demand for quick vaccination raised the expectations from the CROs to rise to the occasion and intensify their vaccine research, clinical trials, testing and developmental efforts, which they did in a record time.
Because of their tremendous efforts, we as a global unit came up with nearly a dozen vaccines already being deployed worldwide, with over sixty-eight percent global population vaccinated at least once.
These are tremendous achievements while these CROs are further advancing their forces to find more possible ways through novel technologies to mitigate the virus spreading and boost the global population’s immunity further.
The momentum will be carried forward as predicted by the Reportlinker’s report. According to the report, the global CRO market is projected to grow at a CAGR of 10.06% during 2022–26 and reach $40 billion by the end of 2026. The report further states that the market will be further driven by the growing biopharmaceutical industry, increased global R&D expenditure and investment, regulations of clinical trials, and technological innovations in the healthcare industry, particularly in the CRO end-user market segment and geographical landscape.
To grasp these very positive scenarios for the present and future of the CRO industry, Insights Care’s team unveiled this exclusive edition of the ’10 Most Innovative CROs To Watch In 2022.’ These ten CROs are among the disruptive innovators when it comes to clinical trials, R&D, and assisting the vaccine development drive. Also included in this edition are two trendy articles our in-house editorial team curated to give you a holistic view of the entire scenario.
